2025 HCPCS Code J2779
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
TAGS: intravitreal implant| Short Description | Inj, susvimo 0.1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | July 01, 2022 |
| HCPCS Action Effective Date | July 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J0799 - Hiv prep, fda approved, noc
- J0800 - Corticotropin injection
- J0801 - Inj. acthar gel to 40 units
- J0802 - Inj. (ani), up to 40 units
- J0833 - Cosyntropin injection nos
- J0834 - Inj., cosyntropin, 0.25 mg
- J0840 - Crotalidae poly immune fab
- J0841 - Inj crotalidae im f(ab')2 eq
- J0850 - Cytomegalovirus imm iv /vial
- J0870 - Injection, imetelstat, 1 mg
- J0872 - Daptomycin (xellia) unrefrig
- J0873 - Inj daptomycin (xellia)
- J0874 - Inj, daptomycin (baxter)
- J0875 - Injection, dalbavancin
- J0877 - Inj, daptomycin (hospira)
- J0878 - Daptomycin injection
- J0879 - Difelikefalin, esrd on dialy
- J0881 - Darbepoetin alfa, non-esrd
- J0882 - Darbepoetin alfa, esrd use
- J0883 - Argatroban nonesrd use 1mg